BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Clin Oncol. Apr 24, 2026; 17(4): 118631
Published online Apr 24, 2026. doi: 10.5306/wjco.v17.i4.118631
Current perspectives on diagnosis and management of primary and secondary breast endometriosis and potential risk of breast cancer
Alexandra G Marneri, Efstathios T Pavlidis, Kalliopi E Stavrati, Christina Mouratidou, Athanasios Kofinas, Irida Konstantopoulou, Theodoros E Pavlidis
Alexandra G Marneri, Breast Unit, 1st Propedeutic Surgical Department, School of Medicine, Kappodistrian University of Athens, Hippokration General Hospital, Athens 1152, Greece
Efstathios T Pavlidis, Theodoros E Pavlidis, The Second Department of Propaedeutic Surgery, Hippokration General Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki 54642, Greece
Kalliopi E Stavrati, Department of Surgical, Eugenideio Hospital, Athens 11528, Greece
Christina Mouratidou, Intensive Care Unit, Hippokration General Hospital, Thessaloniki 54642, Greece
Athanasios Kofinas, Department of Transplantation Surgery, Center for Research and Innovation in Solid Organ Transplantation, Hippokration General Hospital, Aristotle University of Thessaloniki, School of Medicine, Thessaloniki 54642, Greece
Irida Konstantopoulou, Department of Obstetrics and Gynecology, General Hospital of Messinia, Kalamata 24100, Greece
Co-corresponding authors: Efstathios T Pavlidis and Theodoros E Pavlidis.
Author contributions: Marneri AG, Pavlidis ET, and Stavrati KE designed research and analysed data; Mouratidou C, Kofinas A, and Konstantopoulou I performed research, contributed new analytic tools, evaluated data and review the paper; Pavlidis TE analysed data review and approved the paper; Pavlidis ET and Pavlidis TE contributed equally to this manuscript as co-corresponding authors. All authors have read and approved the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Theodoros E Pavlidis, MD, PhD, Professor Emeritus, The Second Department of Propaedeutic Surgery, Hippokration General Hospital, School of Medicine, Aristotle University of Thessaloniki, Konstantinoupoleos 49, Thessaloniki 54642, Greece. pavlidth@auth.gr
Received: January 7, 2026
Revised: January 19, 2026
Accepted: February 27, 2026
Published online: April 24, 2026
Processing time: 104 Days and 16.3 Hours
Abstract

Breast endometriosis represents an exceptionally rare extragenital manifestation of ectopic endometrial tissue, with only a few histologically confirmed breast cases reported worldwide. There appears to be a potential relationship between endometriosis and an increased risk of developing breast cancer. The proposed mechanisms include chronic inflammation, oxidative stress, hormonal dysregulation, and genetic factors such as mutations in the GATA binding protein 2, phosphatase and tensin homolog, Kirsten rat sarcoma viral oncogene homolog, and AT-rich interactive domain-containing protein 1A genes, as well as alterations in circulating microRNAs, primarily miR-199a and the let-7 family of miRNAs. However, the molecular mechanisms underlying this association are not yet fully understood. A structured literature search revealed a small number of primary and secondary breast cases, all of which were confirmed by histopathology. Primary lesions occurred spontaneously, whereas secondary cases were associated with prior breast surgery, suggesting possible implantation of endometrial tissue during surgical manipulation. Morphologic diagnosis relies on identifying endometrial glands and stroma, supported by immunoreactivity for CD10 and paired box gene 8 and negativity for GATA binding protein 2. Clinically, lesions may present as palpable nodules or painful masses, often mimicking malignancy or fat necrosis, particularly in patients with a history of reconstructive or reduction surgery. Complete surgical excision was curative in all reported cases, with no recurrence or malignant transformation documented during follow-up. Although exceedingly rare, recognition of this entity is essential to avoid misdiagnosis and to enhance the understanding of the mechanisms underlying ectopic endometrial implantation in extrapelvic sites such as the breast.

Keywords: Endometriosis; Mammary endometriosis; Rare breast lesions; Genomic profile of endometriosis; Ectopic extrapelvic location; Palpable nodules; Painful masses; Malignant transformation risk

Core Tip: Breast endometriosis constitutes an exceedingly uncommon extragenital presentation of ectopic endometrial tissue, with only a limited number of histologically verified cases documented globally. Endometriosis is associated with increased risks of breast, endometrial, ovarian, and thyroid cancers; melanoma; and non-Hodgkin lymphoma. Given its potential for clinical and radiologic mimicry of malignancy and its implications for surgical management, breast endometriosis warrants awareness among pathologists and breast surgeons. Current genomic research has opened new horizons in both diagnosis and therapy. Surgical excision is the method of choice, offering a permanent cure and no recurrence.